You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis

  • Technology appraisal guidance
  • Reference number: TA276
  • Published:  27 March 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Information for the public

  • Colistimethate sodium and tobramycin dry powders for inhalation for pseudomonas lung infection in cystic fibrosis (PDF 185 KB)

    Published:
    27 March 2013
  • Gwybodaeth i'r cyhoedd (Word 338 KB)

    Published:
    07 October 2013
Back to top